Deals & Cases
MLLStart! advised Clinical Research Ventures (CR Ventures) in its investment into Adiposs SA
Start-up desk MLLStart! advised Clinical Research Ventures (CR Ventures), a global life-science investor with a focus on companies entering Phase I or II clinical trials based in Boston, USA, in its investment in Adiposs SA, a med-tech company and developer of a unique diagnostic product for the non-invasive early detection of body wasting cachexia.
The investment will allow Adiposs to manufacture the first batch of ImageBAT, a first-in-class contrast agent for brown adipose tissue detection, as well as to perform the first-in-human clinical trial.
The team was led by Senior Associate Marco Fusi (Transaction/M&A & Venture Capital) and Karin Oberlin (Partner, Transaction/M&A & Venture Capital).
